Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Effect of candesartan on New York Heart Association functional classResults of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme, European Heart Journal, November 2004, European Society of Cardiology,
DOI: 10.1016/j.ehj.2004.07.025.
You can read the full text:
Contributors
The following have contributed to this page
